TMX Secures strategic investment from Gandel Metals at a 33% premium

Preview text: TMX Secures strategic investment from Gandel Metals at a 33% premium 96 11 September 2026…

Thursday, Sep 10, 2026 at 10:07 PM EasternHubSpot

SharewiseTMX Secures strategic investment from Gandel Metals at a 33% premium

Fit to screenFull size

Using this email in an article? Credit: Sharewise email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: TMX Secures strategic investment from Gandel Metals at a 33% premium
Preview text: TMX Secures strategic investment from Gandel Metals at a 33% premium 96 11 September 2026…
From: enquiries@sharewise.com.au
Brand: Sharewise
ESP: HubSpot
Sent: Thu Sep 10, 2026, 10:07 PM ET
Size: 88 KB
Images: 9
Links: 12, 1 of them buttons
Subject length: 69 characters

Against Sharewise's usual

Sent in the 10 PM hour, which holds 11% of its emails; 17% arrive in the 9 PM hour. The subject is 69 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Sharewise <[email protected]>
Reply-To: [email protected]
Subject: TMX Secures strategic investment from Gandel Metals at a 33% premium
Date: Fri, 11 Sep 2026 12:07:07 +1000
Message-ID domain: bf05x.hubspotemail.net
Return-Path domain: bf05x.hubspotemail.net
DKIM signature: d=bf05x.hubspotemail.net s=hs1; d=sharewise.com.au s=hs1-24076189
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Sep 15, 2026 10:06 PM	Join Our Webinar with Dimerix's Dr Nina Webster!
	Sep 14, 2026 6:36 PM	4DMedical (ASX:4DX, Valuation A$5.3/shr - upgraded) - Owning the Ecosystem
	Sep 14, 2026 4:30 AM	SCX.ai (ASX: SCX) — Canaccord Genuity initiation, A$0.80 price target
	Sep 10, 2026 10:07 PM	TMX Secures strategic investment from Gandel Metals at a 33% premium (this email)
	Sep 9, 2026 9:19 PM	Join Our Webinar with Whitefield's Angus Gluskie!
	Sep 7, 2026 10:07 PM	EchoIQ FDA Rejection - Read-Through for ASX MedTech
	Sep 6, 2026 9:04 PM	Join Us for a Webinar with Clarity Pharmaceuticals!